Cyanotech (CYAN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Jun, 2025Executive summary
Fiscal 2025 net sales increased 5.0% to $24.2 million, driven by strong bulk product demand, while packaged sales declined due to shipment timing.
Gross profit margin improved to 28.4% from 25.8% year-over-year, reflecting higher production volumes and lower costs.
Operating loss narrowed by 45% to $2.5 million, and net loss improved to $3.2 million from $5.3 million in the prior year.
Cash decreased to $0.3 million, with continued reliance on related party credit lines and cost-saving initiatives.
Substantial doubt remains about the ability to continue as a going concern due to recurring losses, negative cash flows, and debt covenant breaches.
Financial highlights
Net sales: $24.2M (up 5.0% year-over-year); gross profit: $6.9M (28.4% margin); operating loss: $2.5M.
Net loss: $3.2M ($0.45/share) vs. $5.3M ($0.81/share) prior year; cash at year-end: $0.3M.
Bulk sales rose 63.2% to $5.0M, offsetting a 5.3% decline in packaged sales to $18.4M.
Operating expenses fell 10.9% to $9.4M, mainly from lower marketing and R&D costs.
Fourth quarter net sales grew 5.5% to $6.3M; quarterly net loss narrowed to $0.6M.
Outlook and guidance
Management remains cautious due to economic uncertainty, shifting demand, and potential new tariffs.
Focus areas include expense management, customer relationship strengthening, and eCommerce optimization.
No specific quantitative guidance provided for fiscal 2026.
Latest events from Cyanotech
- Flat sales, lower margins, and new product launches amid cost pressures and secured financing.CYAN
Q4 20243 Feb 2026 - Net sales up 15% to $5.9M, but gross margin and liquidity pressures persist.CYAN
Q1 20252 Feb 2026 - Annual meeting to elect directors, approve equity plan, and ratify auditor, with governance focus.CYAN
Proxy Filing2 Dec 2025 - Key votes include director elections, a new equity plan, and auditor ratification for 2024.CYAN
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and triennial say-on-pay vote headline the agenda.CYAN
Proxy Filing2 Dec 2025 - Gross margin rose to 30.5% and net loss narrowed despite flat Q1 FY2026 revenue.CYAN
Q1 202623 Nov 2025 - Q2 sales up 19.3%, gross margin at 34.3%, operating income positive, but liquidity risks remain.CYAN
Q2 202618 Nov 2025 - Q2 FY2025 saw lower sales, margin compression, and ongoing liquidity challenges.CYAN
Q2 202513 Jun 2025 - Q3 sales rose 10.6% YoY, but ongoing losses and liquidity risks raise going concern doubts.CYAN
Q3 20255 Jun 2025